SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-043863
Filing Date
2020-04-06
Accepted
2020-04-06 19:04:32
Documents
1
Period of Report
2020-03-27

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2014824d2_4.html 4  
1 OWNERSHIP DOCUMENT tm2014824d2_4.xml 4 31635
  Complete submission text file 0001104659-20-043863.txt   33831
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Issuer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Reporting) CIK: 0001425738 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36327 | Film No.: 20778047

Mailing Address ONE LETTERMAN DRIVE, BUILDING D SUITE D3-300 SAN FRANCISCO CA 94129
Business Address
Green Jeremy (Reporting) CIK: 0001650527 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36327 | Film No.: 20778046